|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/48 | |
| A61P 21/02 |
| (11) | Number of the document | 2552475 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11713577.2 |
| Date of filing the European patent application | 2011-03-29 | |
| (97) | Date of publication of the European application | 2013-02-06 |
| (45) | Date of publication and mention of the grant of the patent | 2016-05-18 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2011/030370 |
| Date | 2011-03-29 |
| (87) | Number | WO 2011/123456 |
| Date | 2011-10-06 |
| (30) | Number | Date | Country code |
| 320667 P | 2010-04-02 | US | |
| 319230 P | 2010-03-30 | US |
| (72) |
TURKEL, Catherine C., US
AURORA, Sheena K., US
DODICK, David W., US
BRIN, Mitchell F., US
|
| (73) |
ALLERGAN, INC.,
2525 Dupont Drive, Irvine, CA 92612,
US
|
| (54) | BOTULINUM TOXIN DOSAGE REGIMEN FOR CHRONIC MIGRAINE PROPHYLAXIS |
| BOTULINUM TOXIN DOSAGE REGIMEN FOR CHRONIC MIGRAINE PROPHYLAXIS |